Form 4: Boston Scientific Director Fujimori Receives Equity Award, Disposes of Shares

Director Yoshiaki Fujimori of Boston Scientific Corp. received an annual equity award and disposed of shares on May 8, 2025.

Summary

• On May 8, 2025, Yoshiaki Fujimori, a director of Boston Scientific Corp., acquired 2,081 shares of common stock through an annual equity award.
• The award is in the form of restricted stock that vests fully upon the next annual meeting of stockholders.
• The value of the award is $215,000, divided by the closing price of the common stock on the grant date.
• On the same day, Fujimori disposed of 4,982 shares of common stock.
• Following these transactions, Fujimori beneficially owns 4,982 shares of Boston Scientific Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The equity award is a positive sign, but the share disposal introduces a slight element of uncertainty. Overall, it's a routine transaction.

Positives

• The equity award to a director signals confidence in the company's future performance.

Negatives

• The disposal of 4,982 shares by the director could be interpreted negatively by some investors, although it may be part of a pre-planned strategy.

Risks

• There are no specific risks mentioned in this document.

Future Outlook

The restricted stock vests upon the next annual meeting of stockholders, indicating a future event tied to the company's governance calendar.

Industry Context

Equity awards are a common practice in the medical device industry to incentivize and retain key personnel like directors. The disposal of shares may be part of a planned diversification strategy or to cover tax obligations related to previous equity grants.

Comparison to Industry Standards

• Equity compensation for directors in the medical device industry varies widely based on company size, performance, and individual contributions.
• Companies like Medtronic and Abbott also utilize restricted stock and stock options as part of their director compensation packages.
• Director compensation packages are often benchmarked against peer companies to ensure competitiveness.

Stakeholder Impact

• The equity award aligns the director's interests with those of the shareholders.
• The share disposal may have a minor impact on the stock price, depending on market perception.

Key Dates

Keywords

equity award, director, BSX, Boston Scientific, Form 4, share disposal, restricted stock, beneficial ownership